Nomura Asset Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Nomura Asset Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25	Closed	-$1.16K	–	1531
2023 Q4	$1.16K	Hold	25	–	–	﹤0.01%	1532
2023 Q3	$1.02K	Hold	25	–	–	﹤0.01%	1544
2023 Q2	$1.21K	Hold	25	–	–	﹤0.01%	1551
2023 Q1	$1.23K	Sell	25 -12,425	-100%	-$639K	﹤0.01%	1544
2022 Q4	$630K	Hold	12,450	–	–	﹤0.01%	848
2022 Q3	$625K	Buy	12,450 +12,425	+49,700%	+$701K	﹤0.01%	839
2022 Q2	$1.65K	Hold	25	–	–	﹤0.01%	1530
2022 Q1	$1.5K	Buy	+25	New	+$1.58K	﹤0.01%	1552
2021 Q4	–	Sell	-3,100	Closed	-$276K	–	1032
2021 Q3	$276K	Hold	3,100	–	–	﹤0.01%	904
2021 Q2	$309K	Hold	3,100	–	–	﹤0.01%	936
2021 Q1	$279K	Buy	+3,100	New	+$306K	﹤0.01%	923

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

SWA

Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Nomura Asset Management's GNOM Position: Q1 2024 in Review

Nomura Asset Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2024, closing a stake of 25 shares — an estimated $1.16K sold.

Nomura Asset Management first reported a position in GNOM in Q1 2021 and held it in 11 quarters. The position peaked at $630K in Q4 2022. 60 funds tracked by Wall St. Rank hold GNOM as of Q1 2024.

Nomura Asset Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
Nomura Asset Management sold 25 Global X Genomics & Biotechnology ETF shares in Q1 2024, an estimated $1.16K.
Nomura Asset Management first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and held it in 11 quarters.
Nomura Asset Management's Global X Genomics & Biotechnology ETF position peaked at $630K in Q4 2022.
60 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2024.

Based on Nomura Asset Management's 13F filing for Q1 2024, filed 13 May 2024.